Munich - Delayed Quote EUR
Denali Therapeutics Inc. (4DN.MU)
12.90
-0.30
(-2.23%)
At close: June 13 at 8:00:48 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-365,542
-347,694
-357,991
-244,716
-211,389
Investing Cash Flow
383,179
-88,756
249,308
-141,387
-21,626
Financing Cash Flow
-19,733
484,304
17,820
310,670
19,348
End Cash Position
60,053
176,535
128,681
219,544
294,977
Income Tax Paid Supplemental Data
--
0
3
47
210
Capital Expenditure
-18,840
-15,912
-12,939
-17,833
-8,500
Issuance of Capital Stock
0
499,253
0
296,215
0
Repayment of Debt
-36,695
-32,338
0
0
--
Free Cash Flow
-384,382
-363,606
-370,930
-262,549
-219,889
12/31/2021 - 3/22/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
UP0.F Ultragenyx Pharmaceutical Inc.
33.40
+3.73%
38I.F Intellia Therapeutics, Inc.
6.79
-9.44%
2L9.F Blueprint Medicines Corporation
109.00
-0.91%
26CA.F ImmunityBio, Inc.
2.6460
-3.18%
2LB.F Iovance Biotherapeutics, Inc.
1.9322
+1.19%
VNDA Vanda Pharmaceuticals Inc.
4.5100
-2.59%
GOVX GeoVax Labs, Inc.
1.0300
-9.65%
TVGN Tevogen Bio Holdings Inc.
1.2400
-2.36%
FBIO Fortress Biotech, Inc.
1.8500
-5.61%
CARM Carisma Therapeutics, Inc.
0.4516
-17.62%